Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Totals |
||
Shortage reports |
150 |
|
| Actual shortage: | 5 (3%) | |
| Anticipated shortage: | 2 (1%) | |
| Avoided shortage: | 4 (3%) | |
| Resolved: | 139 (93%) | |
Discontinuation Reports |
51 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 51 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
34 (17%) |
|
Overdue reports |
1 (14%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-05-04 | 2022-08-05 | 159990 |
| LUTATHERA | 370MBq | SOLUTION | Resolved | 2022-05-06 | 2022-06-14 | 160113 |
| SANDOSTATIN | 100MCG | SOLUTION | Resolved | 2022-05-06 | 2023-02-11 | 160174 |
| ILEVRO | 0.3% | SUSPENSION | Resolved | 2022-06-09 | 2022-10-17 | 162289 |
| TOBRADEX | 0.1% 0.3% | SUSPENSION | Resolved | 2022-07-21 | 2022-08-06 | 165184 |
| TRAVATAN Z | 0.004% | SOLUTION | Resolved | 2022-08-29 | 2023-01-17 | 168148 |
| ISOPTO CARPINE | 2% | LIQUID | Resolved | 2022-08-29 | 2022-09-10 | 168151 |
| CILOXAN | 0.3% | SOLUTION | Resolved | 2022-09-14 | 2022-10-07 | 169228 |
| IZBA | 0.003% | SOLUTION | Resolved | 2022-09-29 | 2023-01-06 | 170482 |
| MAXIDEX | 0.1% | SUSPENSION | Resolved | 2022-09-29 | 2024-01-30 | 170485 |
| ALOMIDE | 0.1% | SOLUTION | Resolved | 2022-09-29 | 2022-10-28 | 170488 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-10-25 | 2023-01-25 | 172560 |
| TRILEPTAL 300 MG | 300MG | TABLET | Resolved | 2022-11-22 | 2023-04-13 | 175426 |
| TRILEPTAL 600 MG | 600MG | TABLET | Resolved | 2022-11-22 | 2023-04-13 | 175429 |
| SANDOSTATIN | 50MCG | SOLUTION | Resolved | 2022-11-22 | 2023-02-11 | 175439 |
| ILEVRO | 0.3% | SUSPENSION | Resolved | 2023-04-13 | 2023-05-19 | 189506 |
| DESFERAL 500MG | 500MG | POWDER FOR SOLUTION | Resolved | 2023-04-28 | 2023-10-04 | 191074 |
| GILENYA | 0.25MG | CAPSULE | Resolved | 2023-04-28 | 2023-06-07 | 191077 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2023-05-19 | 2023-09-27 | 192835 |
| VOLTAREN OPHTHA | 0.1% | SOLUTION | Resolved | 2023-09-27 | 2024-02-03 | 205330 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ONBREZ BREEZHALER | 75MCG | CAPSULE | Discontinued | 2022-06-29 | 2022-07-14 | 163682 |
| ZOFRAN | 4MG | SOLUTION | Discontinued | 2022-06-29 | 2022-10-18 | 163685 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| ZOFRAN | 4MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189513 |
| ZOFRAN | 8MG | TABLET | Discontinued | 2023-04-13 | 2023-05-08 | 189538 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| TASIGNA | 50MG | CAPSULE | Discontinued | 2023-10-19 | 2023-11-06 | 207564 |
| SANDOSTATIN | 100MCG | SOLUTION | Discontinued | 2024-03-22 | 2024-03-22 | 223070 |